Skip to main content

Closed

DXR: Daxor Corporation Stock Analysis | finqOS

Healthcare · Medical - Instruments & Supplies

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth-93.8% / yr

Operating margin6174.2%

ROIC20.2%

Financially safe

Strong

Debt / equity0.00×

Interest coverage580.9×

Current ratio0.00×

Valuation

Unrated

P/E ratio5.8×

Daxor Corporation

DXRNASDAQ Capital Market·USD·Closed

Daxor Corporation

DXRNASDAQ·USD·Closed

$10.50

−0.28%

$10.50

−$0.03 (0.28%)

52W Range

31thpctl

Volume

0.20×avg

Mkt Cap

61.30MUSD

P/E

5.8TTM

Div Yield

–ann

52W Range

31thpctl

Volume

0.20×avg

Market Cap

61.30MUSD

P/E Ratio

5.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings